Biotech Archives - Page 128 of 795

2 minute read

Cytokinetics’ Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst

January 12, 3:38 PM

Novartis halts pursuit of Cytokinetics acquisition, impacting promising heart drug. Analysts estimate $3.6 billion sales for Cytokinetics' cardiomyopathy drug by 2032. Still lead drug aficamten viewed as a distinctive therapy for Hypertrophic Cardiomyopathy.

AZN

1 minute read

FDA
News

Vanda Pharmaceuticals Responds To Recent FDA Guidance

By Benzinga Newsdesk

January 12, 1:28 PM

Communication of novel scientific findings and emerging therapies is crucial to inform healthcare providers about new treatment options that did not exist at the time of their medical training. Innovators who conduct

VNDA

3 minute read

Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Secretly Monitor But Don’t Talk About Yet

By Chris Katje

January 12, 1:00 PM

A look at five stocks seeing increased attention from investors.

DCGO

1 minute read

Regeneron Pharma’s Pipeline Makes This Analyst Turn Bullish

By Priya Nigam

January 12, 11:18 AM

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) won a lawsuit last month against Viatris Inc (NASDAQ: VTRS)

REGN

2 minute read

FDA Identifies ResMed’s Recall Of Certain Ventilator Device Masks With Magnets As Most Serious

By Vandana Singh

January 12, 11:07 AM

ResMed (NYSE: RMD) recalls certain respiratory masks with magnets due to potential interference with medical devices. FDA Class I recall.

RMD

2 minute read

FDA
News

FDA Finds No Evidence Weight-Loss Drugs Cause Suicidal Thoughts

By Erica Kollmann

January 11, 5:55 PM

The FDA released an update on Thursday stating that its preliminary review did not find definitive evidence that the drugs cause suicidal thoughts or actions. However, the FDA investigation will continue because a link could not be ruled out to due the small number of suicidal thoughts or actions observed in both people using the drugs and in the comparative control groups.

LLY

1 minute read

Bionano Announces Peer-Reviewed Publication From Its Clinical Study Designed To Support OGM As Part Of Standard Of Care In Genetic Disease Testing

By Benzinga Newsdesk

January 11, 5:04 PM

Peer-reviewed publication from Broeckel, et al. describes the second phase of a multisite evaluation of optical genome mapping (OGM) in 627 samples (597 unique samples and 30 replicates) Overall, for the entire

BNGO

1 minute read

Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition

By Vandana Singh

January 11, 3:22 PM

Novartis AG (NYSE: NVS) has decided to step back from pursuing the Cytokinetics Inc (NASDAQ: CYTK) acquisition, dealing a blow to the potential deal with the

CYTK

2 minute read

Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo and Lilly’s Dominance

By Vandana Singh

January 11, 12:40 PM

Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positioning themselves to tap into the

ALT

2 minute read

AbbVie’s Strategic Move: ImmunoGen Acquisition Triggers Golden Cross, Yet Valuation Caution Remains

By Surbhi Jain

January 11, 11:01 AM

AbbVie Inc (ABBV) stock is up 15% since acquiring ImmunoGen, but past Golden Cross rallies haven't sustained. With high valuation and competition, investors may want to wait for a pullback.

ABBV